Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FJF30
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,794
Award facts
- Contract value 100% obligated
- $16,793.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,793.80 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Renflexis 100 mg vials, a biosimilar to Remicade used in treating autoimmune conditions. This firm fixed-price delivery order, which represents a non-competitive award under an existing contract vehicle, is scheduled for completion by August 5, 2025, with performance taking place at the vendor's headquarters in Conshohocken, Pennsylvania. The award is classified as a child contract, indicating it derives from a larger prime contract vehicle.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor agreement enables AmerisourceBergen to supply pharmaceuticals and medical commodities globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. The company, as a major pharmaceutical distributor headquartered in Pennsylvania, routinely fulfills federal medical procurement needs through competitively awarded contracts with the DLA Medical Supply Chain, delivering specialized medications and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FJF30?
SPE2DB25FJF30 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FJF30 worth?
The government has obligated $16,794 on SPE2DB25FJF30.
Is contract SPE2DB25FJF30 an order under another contract?
Yes. SPE2DB25FJF30 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJF30 competed?
The extent of competition for SPE2DB25FJF30 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award